US20020083949A1 - Female incontinence control device - Google Patents
Female incontinence control device Download PDFInfo
- Publication number
- US20020083949A1 US20020083949A1 US09/753,511 US75351101A US2002083949A1 US 20020083949 A1 US20020083949 A1 US 20020083949A1 US 75351101 A US75351101 A US 75351101A US 2002083949 A1 US2002083949 A1 US 2002083949A1
- Authority
- US
- United States
- Prior art keywords
- base
- urethra
- legs
- coupled
- supporting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0004—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
- A61F2/0031—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra
- A61F2/005—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra with pressure applied to urethra by an element placed in the vagina
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/25—Artificial sphincters and devices for controlling urinary incontinence
Definitions
- the present invention is broadly concerned with an apparatus and method for controlling urinary incontinence in human females. More particularly, it is directed to a prosthesis which can be inserted intravaginally to reposition and support the urinary bladder.
- Urinary incontinence or involuntary loss of urine from the bladder, is prevalent among adult women. According to the Agency for Health Care research and Quality of the Department of Health and Human services, more than 11 million American women suffer from some form of urinary incontinence. More than $16 billion is spent every year in the United States on incontinence related care. UI is more common in women because pregnancy and childbirth may weaken the bladder supporting muscles in the pelvic floor and cause pelvic organ prolapse. It is also more prevalent in postmenopausal women, who have lower blood levels of estrogen, which helps to maintain muscle tone around the urethra. There are four primary types of UI: stress, functional, urge and overflow incontinence.
- Urge incontinence also known as “overactive bladder”, is the result of involuntary contractions of the detrusor muscle.
- Functional incontinence is the result of impaired mobility or mental function, which may arise for example, secondary to Alzheimer's disease.
- Overflow incontinence is the result of weak bladder muscles, which may arise for example, secondary to nerve damage, or blockage of the urethra. Stress and urge incontinence are most common in women, and often occur together as so-called “mixed” incontinence.
- Stress incontinence is caused by loss of muscular support to the urethra and neck of the bladder. It may be treated surgically, by rehabilitation of the pelvic muscles, and by use of prosthetic devices, known as pessaries, which are inserted into the vagina to support the prolapsed neck of the bladder and urethra. Prosthetic devices are particularly suitable for use by patients who are not surgical candidates or who decline surgery.
- Known intravaginal support devices are of two general types. So-called support pessaries are generally ring shaped, and are retained in place by the pubic bone to exert a spring action against the anterior vaginal wall. So-called space-filling pessaries are held in place by their size or by a suction action against the vaginal walls.
- an intravaginal prosthetic support device or pessary which will align the urethra and reposition and support the bladder in a normal anatomical position. There is also a need for such a support device which does not occlude the urethra or exert excessive pressure on the surrounding tissues.
- the apparatus of the present invention is specifically designed to provide an intravaginal prosthetic device which can support the urinary bladder and align the urethra in correct anatomical position without discomfort or excessive pressure on the urethra or surrounding tissues.
- the present invention is directed to a female incontinence device and method for placement of an intravaginal device for repositioning and supporting the prolapsed neck of the urinary bladder and realigning the urethra both vertically and laterally to achieve normal anatomical position enabling a patient to remain stress-continent.
- the incontinence device of the present invention includes an open, generally droplet-shaped base coupled with a pair of elongate spaced parallel legs shaped to extend in a predetermined configuration in orthogonal relationship to the plane of the base.
- the legs Upon installation in the vaginal canal, the legs provide support for the anterior wall of the vagina and adjacent neck of the urinary bladder at a preconfigured variable distance from the posterior vaginal wall, as well as lateral and vertical alignment and support of the adjacent urethra.
- the base may be coupled with a single leg having a predetermined configuration and extending orthogonal to the plane of the base and attached to the base at both ends.
- the principal objects of the present invention are: to provide an improved apparatus and method for controlling urinary incontinence in women; to provide such an apparatus and method for repositioning and providing lateral and subjacent support to the neck of the bladder and the urethra; to provide such an apparatus and method for supporting the bladder and urethra while providing a templet for lateral alignment of the urethra; to provide such an apparatus and method for supporting the bladder and urethra while correcting the lateral alignment of the urethra; to provide such an apparatus which does not occlude the urethra; to provide such an apparatus which does not require flexed positioning behind the pubic bone to remain in place; to provide such an apparatus which may be positioned manually without surgical intervention; to provide such an apparatus which is available in an array of sizes so that an appropriate size can be selected to fit the pelvic anatomy of a patient; providing such an apparatus which can be easily installed and removed by a patient without assistance; to provide such an apparatus having a pair of spaced parallel legs for
- FIG. 1 is a perspective view of a female incontinence device.
- FIG. 2 is a side elevational view of the female incontinence device of FIG. 1 showing the legs extending a spaced distance in an orthogonal plane from the base.
- FIG. 3 is a top plan view of the device in FIG. 2, showing a longitudinal space between the legs.
- FIG. 4 is a bottom plan view of the device of FIG. 2.
- FIG. 5 is a front elevational view of the apparatus depicted in FIG. 1.
- FIG. 6 is a real elevational view of the device of FIG. 1.
- FIG. 7 is a perspective view of a first modified embodiment of the invention.
- FIG. 8 is a top plan view of the embodiment depicted in FIG. 7.
- FIG. 9 is a side elevational view of the device of FIG. 7.
- FIG. 10 is a bottom plan view of the apparatus depicted in FIG. 7.
- FIG. 11 is a rear elevational view of the apparatus depicted in FIG. 7.
- FIG. 12 is a front elevational view of the device of FIG. 7.
- FIG. 13 is a sagittal sectional view of the female pelvic organs showing the organs in correct anatomical position.
- FIG. 14 is a sectional view similar to that depicted in FIG. 13, showing the urinary bladder prolapsed into the vaginal canal.
- FIG. 15 is a sectional view similar to that depicted in FIG. 13, showing the device of FIG. 1 installed and illustrating repositioning and support of the neck of the urinary bladder and urethra.
- FIG. 16 is a view similar to FIG. 15 showing the device of FIG. 7 installed and illustrating repositioning and support f the urinary bladder and urethra.
- FIG. 17 is a diagrammatic, fragmentary cross-sectional view taken generally along line 17 - 17 of FIG. 15 showing the device 1 supporting a user's urethra.
- FIGS. 13 - 15 illustrate a sagittal sectional view of the human female pelvic organs showing the vagina 2 , which is the functional location of installation of the incontinence device 1 , oriented between the anterior and posterior walls 3 and 4 and adjacent the bladder 5 and urethra 6 , and in particular, adjacent the posterior wall 7 of the bladder 5 .
- the incontinence device 1 broadly includes an open, droplet-shaped base 11 , having an ellipsoid first end 12 which is positioned in a superior orientation during use and an approximately v-shaped convergent second end 13 . During use, the second end 13 is positioned in an inferior orientation.
- a pair of elongate spaced legs 14 and 15 are coupled with the superior first end 12 of the base 11 in parallel relationship with a longitudinal space 16 therebetween.
- the legs 14 and 15 generally extend in parallel planes orthogonal to the plane of the base 11 .
- the legs 14 and 15 are substantially identical, each having a first end 21 and a second end 22 with a central portion 23 therebetween.
- the leg first ends 21 are conjoined adjacent to and coupled with the superior first end 12 of the base 11 .
- the leg central portions 23 are shaped so that each leg forms an approximately S-shaped curve when viewed from the side.
- the unattached leg second ends 22 extend in spaced relationship to the plane of the base 11 and overlie the second end 13 of the base 11 slightly. The leg second ends 22 may be displaced toward the base 11 during deformation of the device 1 upon insertion.
- the distance between the legs 14 and 15 and the base 11 defines an eccentric space 24 .
- each leg 14 and 15 may be further described as comprising a superior portion 26 and an inferior portion 27 .
- the superior portion 26 is curved outwardly from the base 11 and the inferior portion 27 is curved inwardly toward the base 11 , so that overall the legs 14 and 15 have a generally s-shaped configuration when viewed in profile.
- the longitudinal space 16 between the legs 14 and 15 is sized and shaped to receive the urethra 6 and the adjacent portion of the anterior vaginal wall 3 and to form a template for lateral alignment of the urethra.
- the curvature of the central portion 23 of the legs 14 and 15 is adapted for supporting the anterior wall 3 of the vagina 2 and the adjacent prolapsed neck of the bladder 5 and the urethra 6 and maintaining them at a preconfigured variable distance from the posterior vaginal wall 4 .
- each leg 14 and 15 extends outwardly from the base 11 in spaced relationship for a predetermined distance designed to push the prolapsed neck of the bladder 5 away from the posterior wall 4 of the vagina 2 and to maintain the posterior wall 7 and neck of the bladder 5 in normal anatomical position.
- the curvature of the inferior portion 27 of each leg 14 and 15 is adapted to generally conform to and support the anterior vaginal wall 3 adjacent the urethra 6 in normal anatomical position without compressing or otherwise occluding the urethra 6 .
- the second ends 22 of the legs 14 and 15 are not connected to the base 11 , permitting the second ends 22 to flex to a greater degree than the first ends 21 .
- This increased capacity for flexion of the free second ends 22 reduces the likelihood that the inferior portion 27 of the legs 14 and 15 will compress the urethra 6 , while maintaining sufficient rigidity of the superior portion 26 of the legs to maintain the posterior wall 7 of the bladder 5 in normal anatomical position.
- the incontinence device 1 is of unitary construction and is preferably formed by molding an inert, biocompatible synthetic resin material having a modulus of elasticity such as, for example, a molded silicone compound or other suitable biocompatible material or combination of materials.
- the base 11 and legs 14 and 15 are solid circular.
- the base has an outside length of about 25 to about 115 millimeters (mm), with a preferred length of about 95 mm and an outside width at the broadest point of about 25 to about 80 mm, with a preferred width of about 53 mm.
- the legs 14 and 15 extend in parallel planes orthogonal to the plane of the base 11 for about 40 to about 110 mm, with a preferred overall length of about 100 mm.
- the material forming the base 11 and legs 14 and 15 has a diameter of from about 5 to about 14 mm, with a preferred diameter of about 12.5 mm. At the closest point the interior surfaces of the legs 14 and 15 and the interior surface of the base 11 are spaced apart from about 5 mm to about 15, with a preferred spacing of about 10 mm.
- the device 1 is depicted having an open, generally droplet-shaped base and a pair of spaced parallel legs with a generally s-shaped profile.
- the base 11 may be elliptical overall and it may be solid, filled, or webbed rather than open. Where a rectocele is present, such a solid, filled or webbed base configuration is particularly suitable for providing support to the posterior vaginal wall 4 .
- the legs 14 and 15 may be joined by a web, attached to the base 11 at both ends 12 and 13 , or a single wide leg may be provided which bifurcates adjacent the free end.
- the legs 14 and 15 may be constructed to present any suitable profile configuration for supporting the bladder and urethra, such as elliptical, rectangular or complex curvate.
- the shape of the legs 14 and 15 when viewed from the side may also be eccentric rather than symmetrical as depicted in the drawing figures.
- a device 1 having the correct size is selected for use by a patient in accordance with the dimensions of the vaginal canal 2 .
- the patient grasps the device 1 and aligns it so that the base 11 faces posteriorly with the first end 12 in a superior orientation.
- the inferior second leg ends 22 may be compressed against the lower end 13 of the base 11 .
- the patient positions the device at the vaginal orifice and, using the posterior vaginal wall 4 as a guide, the device 1 is slidingly inserted into the canal 2 and urged upwardly until the legs 14 and 15 engage the anterior vaginal wall 3 adjacent the prolapsed neck of the bladder 5 and the lower end 13 of the base 11 and the inferior second ends 22 of the legs are positioned entirely within the canal 2 .
- the elastomeric characteristics of the material permit deformation of the device 1 during insertion, but upon placement, the device assumes its molded shape.
- the incontinence device 1 of the present invention presents a generally s-shaped anterior profile with a planar rear profile when viewed from the side (FIGS. 2 and 15), with the legs 14 and 15 in parallel orientation so that the urethra is aligned within the space 16 between them and the neck of the bladder 5 is engaged and supported by the anteriorly curvate central portions 23 .
- the first chosen device 1 does not comfortably provide the desired support of the bladder 5 and alignment of the urethra 6 , then the device 1 is removed, an alternate device 1 of a larger or smaller size is selected and the process is repeated until the prolapsed neck of the bladder 5 is supported and the urethra is laterally aligned in the space 16 between the legs 14 and 15 of the device as generally shown in FIG. 17.
- the legs 14 and 15 are also adapted to flex separately in response to intra-abdominal torsional forces exerted thereon as the user moves.
- the device 1 aligns and supports, but does not occlude the urethra 6 , thus avoiding the morbidity normally associated with currently available devices.
- the bladder 5 functions normally, without regard to sudden increases in intra abdominal pressure resulting from exercise or other causes.
- voiding is complete, and no residual urine remains in a prolapsed area or cystocele to support bacterial growth which may result in infection.
- the device 1 is installed manually, without the need for an applicator and is similarly removed for periodic cleaning by grasping the legs 14 and 15 and/or the lower end 13 of the base 11 and pulling outwardly through the vaginal canal 2 .
- FIGS. 7 - 12 The structure of a first modified embodiment of a female incontinence device in accordance with the invention is shown in FIGS. 7 - 12 and is generally represented by the reference numeral 101 .
- the device 101 is similar to the embodiment previously described, except that a single leg is employed to support the adjacent bladder 5 and urethra 6 within the vagina 2 between the anterior and posterior walls 3 and 4 .
- the device 101 includes an open, generally droplet shaped base 111 , with an ellipsoid first end 112 and a generally v-shaped second end 113 intercoupled by a support leg 114 .
- the leg 114 extends in a plane orthogonal to the plane of the base 111 .
- the leg 114 includes a first end 115 coupled with the base first end 112 and a second end 116 coupled with the base second end 113 .
- the respective first ends are positioned in a superior orientation during use and the second ends are positioned in an inferior orientation during use.
- the leg first end 115 is coupled with the base first end 112 in a generally orthogonal relationship.
- the leg second end 116 is coupled with the base second end 113 in a stepped fashion, so that the base and leg second ends 113 and 116 cooperatively form a graspable indent 120 (FIGS. 9 and 11).
- the central portion 117 of the leg 114 has an eccentric elliptical shape which increasingly diverges from the plane of the base 111 as it approaches the inferior second end 116 of the leg 114 .
- the construction of the device 101 is similar to that previously described for device 1 .
- the base has a length of about 35 to about 115 mm, with a preferred length of about 95 mm and a width at the broadest point of about 25 to about 80 mm, with a preferred width of about 53 mm.
- the leg extends orthogonal to the plane of the base 111 for a length of about 30 mm to about 60 mm.
- the material forming the base 111 and leg 114 has a diameter of from about 5 to about 14 mm, with a preferred diameter of about 12.5 mm.
- a device 101 is selected in accordance with the dimensions of the vaginal canal 2 .
- the patient grasps the device 101 by the indent 120 and aligns it so that the base 111 faces posteriorly with the first end 112 in a superior orientation and inserts it in a manner substantially similar to the embodiment previously described so that the device 101 is positioned entirely within the canal 2 in remote supporting engagement with the neck of the bladder 5 and the urethra 6 .
- the incontinence device 101 of the present embodiment presents a generally D-shaped profile when viewed from the side (FIG. 9), so that the neck of the bladder 5 is supported against the central portion 117 at its highest point, and the urethra 6 is aligned beneath the bladder.
Landscapes
- Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Prostheses (AREA)
Abstract
Description
- The present invention is broadly concerned with an apparatus and method for controlling urinary incontinence in human females. More particularly, it is directed to a prosthesis which can be inserted intravaginally to reposition and support the urinary bladder.
- Urinary incontinence (UI), or involuntary loss of urine from the bladder, is prevalent among adult women. According to the Agency for Health Care research and Quality of the Department of Health and Human services, more than 11 million American women suffer from some form of urinary incontinence. More than $16 billion is spent every year in the United States on incontinence related care. UI is more common in women because pregnancy and childbirth may weaken the bladder supporting muscles in the pelvic floor and cause pelvic organ prolapse. It is also more prevalent in postmenopausal women, who have lower blood levels of estrogen, which helps to maintain muscle tone around the urethra. There are four primary types of UI: stress, functional, urge and overflow incontinence.
- Stress incontinence occurs when the urethra fails to keep the neck of the bladder closed during exertion. It occurs during sudden increases in intra-abdominal pressure, for example, during physical exertion, lifting, laughing, coughing and sneezing. Urge incontinence, also known as “overactive bladder”, is the result of involuntary contractions of the detrusor muscle. Functional incontinence is the result of impaired mobility or mental function, which may arise for example, secondary to Alzheimer's disease. Overflow incontinence is the result of weak bladder muscles, which may arise for example, secondary to nerve damage, or blockage of the urethra. Stress and urge incontinence are most common in women, and often occur together as so-called “mixed” incontinence.
- Therapeutic treatment of UI in women varies according to type. Functional incontinence is treated by addressing the underlying impairment, if possible. Overflow incontinence is rare in women. While urge incontinence may be treated by anticholinergic drugs, these drugs are not effective in treating stress incontinence.
- Stress incontinence is caused by loss of muscular support to the urethra and neck of the bladder. It may be treated surgically, by rehabilitation of the pelvic muscles, and by use of prosthetic devices, known as pessaries, which are inserted into the vagina to support the prolapsed neck of the bladder and urethra. Prosthetic devices are particularly suitable for use by patients who are not surgical candidates or who decline surgery.
- Previous prosthetic devices have attempted to achieve normal bladder support by applying pressure to the anterior wall of the vagina and adjacent neck of the bladder and urethra. Such anterior pressure does not provide lateral alignment of the urethra and may serve to exacerbate any lateral urethral deviation. Moreover, when such a device exerts pressure on the tissue in excess of 32 mm Hg, the capillaries close, cutting off the cellular blood supply and eventually resulting in necrosis of the adjacent tissue, manifested as vaginal pressure ulcers. Even where such devices do not damage the tissue by exerting excessive pressure, the pressure they do cause results in occlusion of the urethra, setting up a local irritation and attendant patient discomfort. An increase in the incidence of urinary tract infections has been reported in patients who use such prosthetic devices for extended periods of time.
- Known intravaginal support devices are of two general types. So-called support pessaries are generally ring shaped, and are retained in place by the pubic bone to exert a spring action against the anterior vaginal wall. So-called space-filling pessaries are held in place by their size or by a suction action against the vaginal walls. There is a need for an intravaginal prosthetic support device or pessary which will align the urethra and reposition and support the bladder in a normal anatomical position. There is also a need for such a support device which does not occlude the urethra or exert excessive pressure on the surrounding tissues.
- The apparatus of the present invention is specifically designed to provide an intravaginal prosthetic device which can support the urinary bladder and align the urethra in correct anatomical position without discomfort or excessive pressure on the urethra or surrounding tissues.
- The present invention is directed to a female incontinence device and method for placement of an intravaginal device for repositioning and supporting the prolapsed neck of the urinary bladder and realigning the urethra both vertically and laterally to achieve normal anatomical position enabling a patient to remain stress-continent. The incontinence device of the present invention includes an open, generally droplet-shaped base coupled with a pair of elongate spaced parallel legs shaped to extend in a predetermined configuration in orthogonal relationship to the plane of the base. Upon installation in the vaginal canal, the legs provide support for the anterior wall of the vagina and adjacent neck of the urinary bladder at a preconfigured variable distance from the posterior vaginal wall, as well as lateral and vertical alignment and support of the adjacent urethra. Alternatively, the base may be coupled with a single leg having a predetermined configuration and extending orthogonal to the plane of the base and attached to the base at both ends.
- The principal objects of the present invention are: to provide an improved apparatus and method for controlling urinary incontinence in women; to provide such an apparatus and method for repositioning and providing lateral and subjacent support to the neck of the bladder and the urethra; to provide such an apparatus and method for supporting the bladder and urethra while providing a templet for lateral alignment of the urethra; to provide such an apparatus and method for supporting the bladder and urethra while correcting the lateral alignment of the urethra; to provide such an apparatus which does not occlude the urethra; to provide such an apparatus which does not require flexed positioning behind the pubic bone to remain in place; to provide such an apparatus which may be positioned manually without surgical intervention; to provide such an apparatus which is available in an array of sizes so that an appropriate size can be selected to fit the pelvic anatomy of a patient; providing such an apparatus which can be easily installed and removed by a patient without assistance; to provide such an apparatus having a pair of spaced parallel legs for receiving and aligning an adjacent urethra therebetween; to provide a method for inserting such an apparatus intravaginally, positioning the device so that the superior aspects of the legs reposition and support the prolapsed neck of a urinary bladder and the legs laterally align and support the urethra for controlling urinary incontinence in women, and permitting the device to remain in place for an extended period of time; providing such an apparatus and method which are relatively easy to use, inexpensive to produce and particularly well-suited for their intended usage.
- Other objects and advantages of this invention will become apparent from the following description taken in conjunction with the accompanying drawings wherein are set forth, by way of illustration and example, certain embodiments of the invention.
- The drawings constitute a part of this specification and include exemplary embodiments of the present invention and illustrate various objects and features thereof.
- FIG. 1 is a perspective view of a female incontinence device.
- FIG. 2 is a side elevational view of the female incontinence device of FIG. 1 showing the legs extending a spaced distance in an orthogonal plane from the base.
- FIG. 3 is a top plan view of the device in FIG. 2, showing a longitudinal space between the legs.
- FIG. 4 is a bottom plan view of the device of FIG. 2.
- FIG. 5 is a front elevational view of the apparatus depicted in FIG. 1.
- FIG. 6 is a real elevational view of the device of FIG. 1.
- FIG. 7 is a perspective view of a first modified embodiment of the invention.
- FIG. 8 is a top plan view of the embodiment depicted in FIG. 7.
- FIG. 9 is a side elevational view of the device of FIG. 7.
- FIG. 10 is a bottom plan view of the apparatus depicted in FIG. 7.
- FIG. 11 is a rear elevational view of the apparatus depicted in FIG. 7.
- FIG. 12 is a front elevational view of the device of FIG. 7.
- FIG. 13 is a sagittal sectional view of the female pelvic organs showing the organs in correct anatomical position.
- FIG. 14 is a sectional view similar to that depicted in FIG. 13, showing the urinary bladder prolapsed into the vaginal canal.
- FIG. 15 is a sectional view similar to that depicted in FIG. 13, showing the device of FIG. 1 installed and illustrating repositioning and support of the neck of the urinary bladder and urethra.
- FIG. 16 is a view similar to FIG. 15 showing the device of FIG. 7 installed and illustrating repositioning and support f the urinary bladder and urethra.
- FIG. 17 is a diagrammatic, fragmentary cross-sectional view taken generally along line17-17 of FIG. 15 showing the device 1 supporting a user's urethra.
- As required, detailed embodiments of the present invention are disclosed herein; however, it is to be understood that the disclosed embodiments are merely exemplary of the invention, which may be embodied in various forms. Therefore, specific structural and functional details disclosed herein are not to be interpreted as limiting, but merely as a basis for the claims and as a representative basis for teaching one skilled in the art to variously employ the present invention in virtually any appropriately detailed structure.
- Referring now to the drawings, a female incontinence control device is generally indicated by the reference numeral1 and is depicted in FIGS. 1-6. FIGS. 13-15 illustrate a sagittal sectional view of the human female pelvic organs showing the vagina 2, which is the functional location of installation of the incontinence device 1, oriented between the anterior and
posterior walls 3 and 4 and adjacent thebladder 5 andurethra 6, and in particular, adjacent the posterior wall 7 of thebladder 5. - As best shown in FIGS.1-6, the incontinence device 1 broadly includes an open, droplet-
shaped base 11, having an ellipsoidfirst end 12 which is positioned in a superior orientation during use and an approximately v-shaped convergentsecond end 13. During use, thesecond end 13 is positioned in an inferior orientation. A pair of elongate spacedlegs first end 12 of the base 11 in parallel relationship with alongitudinal space 16 therebetween. Thelegs base 11. Thelegs first end 21 and asecond end 22 with acentral portion 23 therebetween. The leg first ends 21 are conjoined adjacent to and coupled with the superiorfirst end 12 of thebase 11. The legcentral portions 23 are shaped so that each leg forms an approximately S-shaped curve when viewed from the side. The unattached leg second ends 22 extend in spaced relationship to the plane of thebase 11 and overlie thesecond end 13 of the base 11 slightly. The leg second ends 22 may be displaced toward the base 11 during deformation of the device 1 upon insertion. The distance between thelegs base 11 defines aneccentric space 24. - The
central portion 23 of eachleg superior portion 26 and aninferior portion 27. Thesuperior portion 26 is curved outwardly from thebase 11 and theinferior portion 27 is curved inwardly toward thebase 11, so that overall thelegs longitudinal space 16 between thelegs urethra 6 and the adjacent portion of the anteriorvaginal wall 3 and to form a template for lateral alignment of the urethra. The curvature of thecentral portion 23 of thelegs anterior wall 3 of the vagina 2 and the adjacent prolapsed neck of thebladder 5 and theurethra 6 and maintaining them at a preconfigured variable distance from the posterior vaginal wall 4. - More specifically, the
superior portion 26 of eachleg bladder 5 away from the posterior wall 4 of the vagina 2 and to maintain the posterior wall 7 and neck of thebladder 5 in normal anatomical position. The curvature of theinferior portion 27 of eachleg vaginal wall 3 adjacent theurethra 6 in normal anatomical position without compressing or otherwise occluding theurethra 6. - In the preferred embodiment, the second ends22 of the
legs base 11, permitting the second ends 22 to flex to a greater degree than the first ends 21. This increased capacity for flexion of the free second ends 22 reduces the likelihood that theinferior portion 27 of thelegs urethra 6, while maintaining sufficient rigidity of thesuperior portion 26 of the legs to maintain the posterior wall 7 of thebladder 5 in normal anatomical position. - The incontinence device1 is of unitary construction and is preferably formed by molding an inert, biocompatible synthetic resin material having a modulus of elasticity such as, for example, a molded silicone compound or other suitable biocompatible material or combination of materials. In cross section, the
base 11 andlegs legs base 11 for about 40 to about 110 mm, with a preferred overall length of about 100 mm. The material forming thebase 11 andlegs legs - The device1 is depicted having an open, generally droplet-shaped base and a pair of spaced parallel legs with a generally s-shaped profile. Other suitable configurations may be employed. For example, the
base 11 may be elliptical overall and it may be solid, filled, or webbed rather than open. Where a rectocele is present, such a solid, filled or webbed base configuration is particularly suitable for providing support to the posterior vaginal wall 4. Thelegs legs legs - In use, a device1 having the correct size is selected for use by a patient in accordance with the dimensions of the vaginal canal 2. The patient grasps the device 1 and aligns it so that the base 11 faces posteriorly with the
first end 12 in a superior orientation. In order to facilitate grasping and placement of the device, the inferior second leg ends 22 may be compressed against thelower end 13 of thebase 11. The patient positions the device at the vaginal orifice and, using the posterior vaginal wall 4 as a guide, the device 1 is slidingly inserted into the canal 2 and urged upwardly until thelegs vaginal wall 3 adjacent the prolapsed neck of thebladder 5 and thelower end 13 of thebase 11 and the inferior second ends 22 of the legs are positioned entirely within the canal 2. The elastomeric characteristics of the material permit deformation of the device 1 during insertion, but upon placement, the device assumes its molded shape. - Thus positioned, the incontinence device1 of the present invention presents a generally s-shaped anterior profile with a planar rear profile when viewed from the side (FIGS. 2 and 15), with the
legs space 16 between them and the neck of thebladder 5 is engaged and supported by the anteriorly curvatecentral portions 23. - If the first chosen device1 does not comfortably provide the desired support of the
bladder 5 and alignment of theurethra 6, then the device 1 is removed, an alternate device 1 of a larger or smaller size is selected and the process is repeated until the prolapsed neck of thebladder 5 is supported and the urethra is laterally aligned in thespace 16 between thelegs legs - Advantageously, the device1 aligns and supports, but does not occlude the
urethra 6, thus avoiding the morbidity normally associated with currently available devices. Maintained in place by the device 1, thebladder 5 functions normally, without regard to sudden increases in intra abdominal pressure resulting from exercise or other causes. In addition, because thebladder 5 is fully supported and theurethra 6 is aligned, voiding is complete, and no residual urine remains in a prolapsed area or cystocele to support bacterial growth which may result in infection. - The device1 is installed manually, without the need for an applicator and is similarly removed for periodic cleaning by grasping the
legs lower end 13 of thebase 11 and pulling outwardly through the vaginal canal 2. - While an exemplary configuration of an incontinence device having generally s-shaped
legs legs bladder 5 andurethra 6. - The structure of a first modified embodiment of a female incontinence device in accordance with the invention is shown in FIGS.7-12 and is generally represented by the
reference numeral 101. Thedevice 101 is similar to the embodiment previously described, except that a single leg is employed to support theadjacent bladder 5 andurethra 6 within the vagina 2 between the anterior andposterior walls 3 and 4. - In particular, as best shown in FIG. 10, the
device 101 includes an open, generally droplet shapedbase 111, with an ellipsoidfirst end 112 and a generally v-shapedsecond end 113 intercoupled by asupport leg 114. As best shown in FIG. 12, theleg 114, extends in a plane orthogonal to the plane of thebase 111. Theleg 114 includes afirst end 115 coupled with the basefirst end 112 and asecond end 116 coupled with the basesecond end 113. The respective first ends are positioned in a superior orientation during use and the second ends are positioned in an inferior orientation during use. The legfirst end 115 is coupled with the basefirst end 112 in a generally orthogonal relationship. The legsecond end 116 is coupled with the basesecond end 113 in a stepped fashion, so that the base and leg second ends 113 and 116 cooperatively form a graspable indent 120 (FIGS. 9 and 11). - The
central portion 117 of theleg 114 has an eccentric elliptical shape which increasingly diverges from the plane of the base 111 as it approaches the inferiorsecond end 116 of theleg 114. - The construction of the
device 101 is similar to that previously described for device 1. The base has a length of about 35 to about 115 mm, with a preferred length of about 95 mm and a width at the broadest point of about 25 to about 80 mm, with a preferred width of about 53 mm. The leg extends orthogonal to the plane of thebase 111 for a length of about 30 mm to about 60 mm. The material forming thebase 111 andleg 114 has a diameter of from about 5 to about 14 mm, with a preferred diameter of about 12.5 mm. - In use, a
device 101 is selected in accordance with the dimensions of the vaginal canal 2. The patient grasps thedevice 101 by theindent 120 and aligns it so that the base 111 faces posteriorly with thefirst end 112 in a superior orientation and inserts it in a manner substantially similar to the embodiment previously described so that thedevice 101 is positioned entirely within the canal 2 in remote supporting engagement with the neck of thebladder 5 and theurethra 6. - Thus positioned, the
incontinence device 101 of the present embodiment presents a generally D-shaped profile when viewed from the side (FIG. 9), so that the neck of thebladder 5 is supported against thecentral portion 117 at its highest point, and theurethra 6 is aligned beneath the bladder. - It is to be understood that while certain forms of the present invention have been illustrated and described herein, it is not to be limited to the specific forms or arrangement of parts described and shown. In particular, the configuration of any of the legs described may be employed in either of the embodiments described, or a leg or legs of an infinite variety of shapes may be employed, regardless of whether both ends of the leg are coupled with the base.
Claims (17)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/753,511 US6460542B1 (en) | 2001-01-03 | 2001-01-03 | Female incontinence control device |
PCT/US2001/020878 WO2002053071A1 (en) | 2001-01-03 | 2001-06-29 | Female incontinence control device |
GBGB0216120.6A GB0216120D0 (en) | 2001-01-03 | 2001-06-29 | Female incontinence control device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/753,511 US6460542B1 (en) | 2001-01-03 | 2001-01-03 | Female incontinence control device |
Publications (2)
Publication Number | Publication Date |
---|---|
US20020083949A1 true US20020083949A1 (en) | 2002-07-04 |
US6460542B1 US6460542B1 (en) | 2002-10-08 |
Family
ID=25030945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/753,511 Expired - Fee Related US6460542B1 (en) | 2001-01-03 | 2001-01-03 | Female incontinence control device |
Country Status (3)
Country | Link |
---|---|
US (1) | US6460542B1 (en) |
GB (1) | GB0216120D0 (en) |
WO (1) | WO2002053071A1 (en) |
Cited By (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6676594B1 (en) | 2002-09-18 | 2004-01-13 | Kimberly-Clark Worldwide, Inc. | C-shaped vaginal incontinence insert |
WO2004045457A1 (en) * | 2002-11-15 | 2004-06-03 | Carey Tasca Pty Ltd | Method of surgical repair of vagina damaged by pelvic organ prolapse and prosthetic materials and devices suitable for use therein |
US6770025B2 (en) | 2002-09-18 | 2004-08-03 | Kimberly-Clark Worldwide, Inc. | Molar shaped vaginal incontinence insert |
US20040172048A1 (en) * | 2001-03-30 | 2004-09-02 | James Browning | Surgical implant |
US6808485B2 (en) | 2002-12-23 | 2004-10-26 | Kimberly-Clark Worldwide, Inc. | Compressible resilient incontinence insert |
US20040249473A1 (en) * | 2003-03-28 | 2004-12-09 | Analytic Biosurgical Solutions- Abiss | Implant for treating rectocele and a device for putting said implant into place |
US20040249397A1 (en) * | 2003-03-28 | 2004-12-09 | Analytic Biosurgical Solutions- Abiss | Method and implant for curing cystocele |
WO2005112842A1 (en) * | 2004-05-21 | 2005-12-01 | Mpathy Medical Devices Limited | Implant for treatment of vaginal and/or uterine prolapse |
US20050288692A1 (en) * | 2004-06-15 | 2005-12-29 | Jean-Marc Beraud | Parietal hook |
US20060058578A1 (en) * | 2002-04-11 | 2006-03-16 | Gyne Ideas Limited | Apparatus and method for treating female urinary incontinence |
US20060173468A1 (en) * | 2005-01-28 | 2006-08-03 | Marc Simmon | Obturator introducer with snare |
US20060205995A1 (en) * | 2000-10-12 | 2006-09-14 | Gyne Ideas Limited | Apparatus and method for treating female urinary incontinence |
FR2890554A1 (en) * | 2005-09-14 | 2007-03-16 | Braun Medical Sas Soc Par Acti | DEVICE AND METHOD FOR PREVENTING FEMALE URINARY INCONTINENCE IN THE EFFORT |
US20070244352A1 (en) * | 2003-05-22 | 2007-10-18 | Contipi Ltd. | Apparatus for the Prevention of Urinary Incontinence in Females |
US20080149109A1 (en) * | 2004-03-18 | 2008-06-26 | Elan Ziv | Apparatus For the Treatment of Feminine Pelvic Organ Prolapse |
US20080281149A1 (en) * | 2005-03-17 | 2008-11-13 | Contipi Ltd | Apparatuses for the Amelioration of Urinary Incontinence in Females |
US20080287968A1 (en) * | 2007-05-14 | 2008-11-20 | Smith Daniel J | Implants and methods for pelvic floor repair |
US20080287956A1 (en) * | 2007-05-14 | 2008-11-20 | Smith Daniel J | Instruments for implanting implantable prostheses |
US20090266367A1 (en) * | 2008-04-23 | 2009-10-29 | Contipi Ltd. | Pessaries for prolapse alleviation |
US20090283099A1 (en) * | 2006-12-21 | 2009-11-19 | Oz Harmanli | Vaginal pessary |
JP2009543606A (en) * | 2006-07-10 | 2009-12-10 | マクニール−ピーピーシー・インコーポレイテッド | Elastic device |
US20090318750A1 (en) * | 2006-07-16 | 2009-12-24 | Contipi Ltd | Apparatuses for the amelioration of urinary incontinence in females |
US7717892B2 (en) | 2006-07-10 | 2010-05-18 | Mcneil-Ppc, Inc. | Method of treating urinary incontinence |
US20100217068A1 (en) * | 2007-10-01 | 2010-08-26 | Elan Ziv | Management of urinary incontinence in females |
US7789821B2 (en) | 2000-10-12 | 2010-09-07 | Gyne Ideas Ltd. | Apparatus and method for treating female urinary incontinence |
WO2010138892A2 (en) | 2009-05-28 | 2010-12-02 | Contine Corporation | Correction of stress urinary incontinence |
US20110065980A1 (en) * | 2007-06-11 | 2011-03-17 | Contipi Ltd. | Adjustable tension ring for amelioration of urinary incontinence in females |
US8167785B2 (en) | 2000-10-12 | 2012-05-01 | Coloplast A/S | Urethral support system |
US20130158340A1 (en) * | 2011-12-20 | 2013-06-20 | Amanda Rae Altan | Vaginal Insert Device Having Perpendicular Segments |
US8469875B2 (en) | 2000-07-05 | 2013-06-25 | Coloplast A/S | Method and device for treating urinary incontinence |
US8608639B2 (en) | 2006-07-10 | 2013-12-17 | Mcneil-Ppc, Inc. | Resilient device |
US8709471B2 (en) | 2003-03-27 | 2014-04-29 | Coloplast A/S | Medicament delivery device and a method of medicament delivery |
US9005222B2 (en) | 2002-08-02 | 2015-04-14 | Coloplast A/S | Self-anchoring sling and introducer system |
AU2013211480B2 (en) * | 2006-07-16 | 2015-06-04 | Kimberly-Clark Worldwide, Inc. | Apparatuses For The Amelioration Of Urinary Incontinence In Females |
US20150351886A1 (en) * | 2013-01-17 | 2015-12-10 | Carey Tasca Pty Ltd | Surgical vaginal support device for surgical treatment of pelvic organ prolapse |
US20160016040A1 (en) * | 2012-06-04 | 2016-01-21 | Caryn M. Horsley | Medical Exercise Device |
ES2577537A1 (en) * | 2016-03-22 | 2016-07-15 | Carmen Rocio SIERRA LABARTA | Collector and urine separator for women (Machine-translation by Google Translate, not legally binding) |
WO2018022492A1 (en) * | 2016-07-25 | 2018-02-01 | Rinovum Subsidiary 2, LLC | Incontinence device |
WO2018022487A1 (en) * | 2016-07-25 | 2018-02-01 | Rinovum Subsidiary 2, LLC | Incontinence device |
US20180132991A1 (en) * | 2010-04-02 | 2018-05-17 | Gynamics Women's Health Ltd. | Medical device for treatment of urinary incontinence in females |
US10004584B2 (en) | 2006-07-10 | 2018-06-26 | First Quality Hygienic, Inc. | Resilient intravaginal device |
USD832437S1 (en) | 2017-07-24 | 2018-10-30 | Rinovum Subsidiary 2, LLC | Incontinence device |
USD833009S1 (en) | 2017-07-24 | 2018-11-06 | Rinovum Subsidiary 2, LLC | Incontinence device |
US10219884B2 (en) | 2006-07-10 | 2019-03-05 | First Quality Hygienic, Inc. | Resilient device |
US11141255B2 (en) | 2017-04-26 | 2021-10-12 | Ovala, Inc. | Introducer for urinary incontinence |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9023031B2 (en) | 1997-08-13 | 2015-05-05 | Verathon Inc. | Noninvasive devices, methods, and systems for modifying tissues |
US7306591B2 (en) | 2000-10-02 | 2007-12-11 | Novasys Medical, Inc. | Apparatus and methods for treating female urinary incontinence |
US7179219B2 (en) | 2001-11-20 | 2007-02-20 | Ams Research Corporation | Incontinence treatment with urethral guide |
US20060205996A1 (en) * | 2001-11-20 | 2006-09-14 | Solorant Medical, Inc. | Incontinence treatment with urethral guide |
US6685623B2 (en) * | 2001-11-20 | 2004-02-03 | Surx, Inc. | Incontinence treatment with urethral guide |
US6739341B2 (en) * | 2002-05-15 | 2004-05-25 | Conticare Medical, Inc. | Incontinence device insertion kit |
US7263999B2 (en) * | 2002-10-30 | 2007-09-04 | Kabushiki Kaisha Kitazato Supply | Ring for preventing prolapse of uterus and urinary bladder and ring for preventing prolapse of uterus and rectum |
IL164563A0 (en) * | 2004-10-13 | 2005-12-18 | Protech Medical Technologies L | Prostate treatment stent |
US7942806B2 (en) * | 2005-12-29 | 2011-05-17 | Ethicon, Inc. | Stress urinary incontinence implant and device for deploying same |
WO2007106897A2 (en) * | 2006-03-15 | 2007-09-20 | Dennis Miller | System and method for treating tissue wall prolapse |
AU2012230102B2 (en) * | 2006-07-10 | 2014-07-10 | First Quality Hygienic, Inc. | Method for treating urinary incontinence |
BRPI0714186A2 (en) * | 2006-07-10 | 2012-12-25 | Mcneil Ppc Inc | Method for treating urinary incontinence |
US9398984B2 (en) | 2008-03-31 | 2016-07-26 | First Quality Hygienie, Inc. | Adjustable applicator for urinary incontinence devices |
US20110105830A1 (en) | 2009-10-30 | 2011-05-05 | Mari Hou | Applicator for Self-Expanding Intravaginal Urinary Incontinence Devices |
BR112012012442A2 (en) | 2009-11-24 | 2018-03-13 | Contipi Ltd | apparatus for the treatment of stress and urgency urinary incontinence |
US20120136199A1 (en) | 2010-11-30 | 2012-05-31 | Mari Hou | Cushioned Resilient Intravaginal Urinary Incontinence Device |
AU2012262093B2 (en) | 2011-06-03 | 2016-07-21 | First Quality Hygienic, Inc. | Cushioned resilient intravaginal urinary incontinence device and method of making same |
US20140005469A1 (en) * | 2012-06-27 | 2014-01-02 | Urova Medical, Inc. | Implants for stress urinary incontinence treatments and related methods |
US9186234B2 (en) | 2013-04-23 | 2015-11-17 | Terell Reglin | Apparatus for promoting urorectal organ emptying and related method |
US9782244B2 (en) | 2013-12-20 | 2017-10-10 | Kimberly-Clark Worldwide, Inc. | Vaginal insert method of manufacture |
US10159550B2 (en) | 2013-12-20 | 2018-12-25 | Kimberly-Clark Worldwide, Inc. | Vaginal insert method of manufacture |
EP3573576B8 (en) | 2017-01-24 | 2022-04-27 | Liv Labs Inc. | Stress urinary incontinence (sui) device |
CN111386065B (en) * | 2017-11-10 | 2023-09-29 | 赫根贝格尔窥器有限公司 | Vagina endoscope |
EP4248910A1 (en) | 2022-03-24 | 2023-09-27 | Juan Llopis Manzanera | Prolapse corrective device |
WO2023212798A1 (en) * | 2022-05-06 | 2023-11-09 | Femtherapeutics Inc. | Gynecological prosthetic with anchor members and expandable connecting links, and method for custom-designing the same |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3554184A (en) | 1968-04-17 | 1971-01-12 | Henry N Habib | Pubo-vaginal incontinence device |
FR2297031A1 (en) * | 1975-01-07 | 1976-08-06 | Rhone Poulenc Ind | Closure device for implantable tubes - having soft, flexible cylindrical hollow body,and openable flexible closure within body |
US4139006A (en) | 1977-03-18 | 1979-02-13 | Corey Arthur E | Female incontinence device |
DE2747245A1 (en) * | 1977-10-21 | 1979-04-26 | Walter Koss | Resilient plug for anus - has support plate carrying flexible skin filled with soft rubber or plastics foam material |
US4669478A (en) | 1985-03-21 | 1987-06-02 | Robertson Jack R | Device for diagnosing and relieving female incontinence |
US4749186A (en) * | 1986-02-10 | 1988-06-07 | Harding Randle Andreaa | Gynecology exercise device |
FR2595564A1 (en) * | 1986-03-11 | 1987-09-18 | Lavarenne Vincent | URETRAL ENDOPROTHESIS |
US4920986A (en) | 1986-10-14 | 1990-05-01 | Zedlani Pty. Limited | Urinary incontinence device |
US5386836A (en) | 1986-10-14 | 1995-02-07 | Zedlani Pty Limited | Urinary incontinence device |
US5007894A (en) | 1989-02-10 | 1991-04-16 | Goran Enhorning | Female incontinence device |
DE19544162C1 (en) | 1995-11-17 | 1997-04-24 | Ethicon Gmbh | Implant for suspension of the bladder in urinary incontinence in women |
US5771899A (en) | 1996-03-14 | 1998-06-30 | Bioteque America Inc. | Pessary |
US5785640A (en) | 1996-05-23 | 1998-07-28 | Kresch; Arnold J. | Method for treating female incontinence |
US5755236A (en) | 1996-12-12 | 1998-05-26 | Dann; Jeffrey A. | Female incontinence device |
-
2001
- 2001-01-03 US US09/753,511 patent/US6460542B1/en not_active Expired - Fee Related
- 2001-06-29 GB GBGB0216120.6A patent/GB0216120D0/en not_active Ceased
- 2001-06-29 WO PCT/US2001/020878 patent/WO2002053071A1/en active Application Filing
Cited By (146)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8920304B2 (en) | 2000-07-05 | 2014-12-30 | Coloplast A/S | Method and device for treating urinary incontinence |
US8469875B2 (en) | 2000-07-05 | 2013-06-25 | Coloplast A/S | Method and device for treating urinary incontinence |
US10278800B2 (en) | 2000-07-05 | 2019-05-07 | Coloplast A/S | Method and device for treating urinary incontinence |
US8801596B2 (en) | 2000-10-12 | 2014-08-12 | Coloplast A/S | Sling with support and suspending members formed from same polymer |
US9113992B2 (en) | 2000-10-12 | 2015-08-25 | Coloplast A/S | Apparatus and method for treating urinary incontinence |
US9918817B2 (en) | 2000-10-12 | 2018-03-20 | Coloplast A/S | Method of post-operatively adjusting a urethral support in treating urinary incontinence of a woman |
US8574148B2 (en) | 2000-10-12 | 2013-11-05 | Coloplast A/S | System for introducing soft tissue anchors |
US9089396B2 (en) | 2000-10-12 | 2015-07-28 | Coloplast A/S | Urinary incontinence treatment and devices |
US8512223B2 (en) | 2000-10-12 | 2013-08-20 | Coloplast A/S | Pelvic implant with selective locking anchor |
US8932202B2 (en) | 2000-10-12 | 2015-01-13 | Coloplast A/S | Incontinence implant with soft tissue anchors and length not allowing abdominal wall penetration |
US10076394B2 (en) | 2000-10-12 | 2018-09-18 | Coloplast A/S | Method of treating urinary incontinence |
US8920308B2 (en) | 2000-10-12 | 2014-12-30 | Coloplast A/S | Surgical implant with anchor introducer channel |
US8911347B2 (en) | 2000-10-12 | 2014-12-16 | Coloplast A/S | System and method for treating urinary incontinence |
US20060205995A1 (en) * | 2000-10-12 | 2006-09-14 | Gyne Ideas Limited | Apparatus and method for treating female urinary incontinence |
US8888678B2 (en) | 2000-10-12 | 2014-11-18 | Coloplast A/S | Pelvic implant with suspending system |
US8852075B2 (en) | 2000-10-12 | 2014-10-07 | Coloplast A/S | Pelvic implant systems and methods with expandable anchors |
US8821369B2 (en) | 2000-10-12 | 2014-09-02 | Colorplast A/S | Method for soft tissue anchoring with introducer |
US8821370B2 (en) | 2000-10-12 | 2014-09-02 | Coloplast A/S | Device, system and methods for introducing soft tissue anchors |
US8007430B2 (en) | 2000-10-12 | 2011-08-30 | Coloplast A/S | Apparatus and method for treating female urinary incontinence |
US7789821B2 (en) | 2000-10-12 | 2010-09-07 | Gyne Ideas Ltd. | Apparatus and method for treating female urinary incontinence |
US9968430B2 (en) | 2000-10-12 | 2018-05-15 | Coloplast A/S | Surgical device implantable to treat female urinary incontinence |
US9089394B2 (en) | 2000-10-12 | 2015-07-28 | Coloplast A/S | Pelvic implant with suspending system |
US10449025B2 (en) | 2000-10-12 | 2019-10-22 | Coloplast A/S | Surgical device implantable to treat female urinary incontinence |
US8469877B2 (en) | 2000-10-12 | 2013-06-25 | Coloplast A/S | System for introducing a pelvic implant |
US8454492B2 (en) | 2000-10-12 | 2013-06-04 | Coloplast A/S | Absorbable anchor and method for mounting mesh to tissue |
US8449450B2 (en) | 2000-10-12 | 2013-05-28 | Coloplast A/S | Pass through introducer and sling |
US8273011B2 (en) | 2000-10-12 | 2012-09-25 | Coloplast A/S | Adjustable surgical implant and method for treating urinary incontinence |
US8182412B2 (en) | 2000-10-12 | 2012-05-22 | Coloplast A/S | Pelvic implant with fibrous anchor |
US8182413B2 (en) | 2000-10-12 | 2012-05-22 | Coloplast A/S | Method for fibrous anchoring of a pelvic support |
US8167785B2 (en) | 2000-10-12 | 2012-05-01 | Coloplast A/S | Urethral support system |
US8162818B2 (en) | 2000-10-12 | 2012-04-24 | Coloplast A/S | Adjustable surgical implant for pelvic anatomy |
US8128554B2 (en) | 2000-10-12 | 2012-03-06 | Coloplast A/S | System for introducing a pelvic implant |
US8123673B2 (en) | 2000-10-12 | 2012-02-28 | Coloplast A/S | Adjustable surgical implant for treating urinary incontinence |
US8118728B2 (en) | 2000-10-12 | 2012-02-21 | Coloplast A/S | Method for implanting an adjustable surgical implant for treating urinary incontinence |
US8118727B2 (en) | 2000-10-12 | 2012-02-21 | Coloplast A/S | Method for supporting pelvic anatomy |
US8047983B2 (en) | 2000-10-12 | 2011-11-01 | Coloplast A/S | Surgical system for supporting pelvic anatomy |
US8668635B2 (en) | 2000-10-12 | 2014-03-11 | Coloplast A/S | Pelvic implant with suspending system |
US20100280308A1 (en) * | 2000-10-12 | 2010-11-04 | Gyne Ideas Ltd. | Apparatus and method for treating female urinary incontinence |
US8603119B2 (en) | 2001-03-30 | 2013-12-10 | Coloplast A/S | Surgical implant having strands and methods of use |
US20040172048A1 (en) * | 2001-03-30 | 2004-09-02 | James Browning | Surgical implant |
US10682213B2 (en) | 2001-03-30 | 2020-06-16 | Coloplast A/S | Surgical implant consisting of non-absorbable material |
US9943390B2 (en) | 2001-03-30 | 2018-04-17 | Coloplast A/S | Method of treating pelvic organ prolapse in a female patient by accessing a prolapsed organ trans-vaginally through a vagina |
US8157821B2 (en) | 2001-03-30 | 2012-04-17 | Coloplast A/S | Surgical implant |
US20100222794A1 (en) * | 2001-03-30 | 2010-09-02 | Mpathy Medical Devices Limited | Surgical Implant |
US8157822B2 (en) | 2001-03-30 | 2012-04-17 | Coloplast A/S | Surgical implant and methods of use |
US8100924B2 (en) | 2001-03-30 | 2012-01-24 | Coloplast A/S | Surgical implant |
US9248011B2 (en) | 2001-03-30 | 2016-02-02 | Coloplast A/S | Surgical implant and methods of use |
US8632554B2 (en) | 2001-03-30 | 2014-01-21 | Coloplast A/S | Low mass density surgical implant having strands and methods of use |
US8603120B2 (en) | 2001-03-30 | 2013-12-10 | Coloplast A/S | Low mass density surgical implant and methods of use |
US20060058578A1 (en) * | 2002-04-11 | 2006-03-16 | Gyne Ideas Limited | Apparatus and method for treating female urinary incontinence |
US9005222B2 (en) | 2002-08-02 | 2015-04-14 | Coloplast A/S | Self-anchoring sling and introducer system |
US9532862B2 (en) | 2002-08-02 | 2017-01-03 | Coloplast A/S | Self-anchoring sling and introducer system |
US9532861B2 (en) | 2002-08-02 | 2017-01-03 | Coloplast A/S | Self-anchoring sling and introducer system |
US9872750B2 (en) | 2002-08-02 | 2018-01-23 | Coloplast A/S | Self-anchoring sling and introducer system |
US6770025B2 (en) | 2002-09-18 | 2004-08-03 | Kimberly-Clark Worldwide, Inc. | Molar shaped vaginal incontinence insert |
US6676594B1 (en) | 2002-09-18 | 2004-01-13 | Kimberly-Clark Worldwide, Inc. | C-shaped vaginal incontinence insert |
WO2004026172A3 (en) * | 2002-09-18 | 2004-04-29 | Kimberly Clark Co | C-shaped vaginal incontinence insert |
AU2003233612B2 (en) * | 2002-09-18 | 2008-04-24 | Kimberly-Clark Worldwide, Inc. | C-shaped vaginal incontinence insert |
WO2004045457A1 (en) * | 2002-11-15 | 2004-06-03 | Carey Tasca Pty Ltd | Method of surgical repair of vagina damaged by pelvic organ prolapse and prosthetic materials and devices suitable for use therein |
US20100154801A1 (en) * | 2002-11-15 | 2010-06-24 | Carey Marcus P | Method of surgical repair of vagina damaged by pelvic organ prolapse and prosthetic materials and devices suitable for use therein |
US20060130848A1 (en) * | 2002-11-15 | 2006-06-22 | Carey Marcus P | Method of surgical repair of vagina damaged by pelvic organ prolapse and prosthetic materials and devices suitable for use therein |
US8201559B2 (en) | 2002-11-15 | 2012-06-19 | Ethicon, Inc. | Method of surgical repair of vagina damaged by pelvic organ prolapse and prosthetic materials and devices suitable for use therein |
US7628155B2 (en) | 2002-11-15 | 2009-12-08 | Ethicon, Inc. | Method of surgical repair of vagina damaged by pelvic organ prolapse and prosthetic materials and devices suitable for use therein |
US6808485B2 (en) | 2002-12-23 | 2004-10-26 | Kimberly-Clark Worldwide, Inc. | Compressible resilient incontinence insert |
US9345867B2 (en) | 2003-03-27 | 2016-05-24 | Coloplast A/S | Device implantable in tissue of a prostate gland or a bladder |
US9186489B2 (en) | 2003-03-27 | 2015-11-17 | Coloplast A/S | Implantable delivery device system for delivery of a medicament to a bladder |
US8709471B2 (en) | 2003-03-27 | 2014-04-29 | Coloplast A/S | Medicament delivery device and a method of medicament delivery |
US9555168B2 (en) | 2003-03-27 | 2017-01-31 | Coloplast A/S | System for delivery of medication in treatment of disorders of the pelvis |
US20040249397A1 (en) * | 2003-03-28 | 2004-12-09 | Analytic Biosurgical Solutions- Abiss | Method and implant for curing cystocele |
US20040249473A1 (en) * | 2003-03-28 | 2004-12-09 | Analytic Biosurgical Solutions- Abiss | Implant for treating rectocele and a device for putting said implant into place |
US20070244352A1 (en) * | 2003-05-22 | 2007-10-18 | Contipi Ltd. | Apparatus for the Prevention of Urinary Incontinence in Females |
US9737389B2 (en) | 2003-05-22 | 2017-08-22 | Kimberly-Clark Worldwide, Inc. | Apparatus for the prevention of urinary incontinence in females |
US10405959B2 (en) | 2003-05-22 | 2019-09-10 | Kimberly-Clark Worldwide, Inc. | Apparatus for the prevention of urinary incontinence in females |
US8727961B2 (en) | 2003-05-22 | 2014-05-20 | Kimberly-Clark Worldwide, Inc. | Apparatus for the prevention of urinary incontinence in females |
US8127768B2 (en) * | 2004-03-18 | 2012-03-06 | Contipi Ltd. | Apparatus for the treatment of feminine pelvic organ prolapse |
US20080149109A1 (en) * | 2004-03-18 | 2008-06-26 | Elan Ziv | Apparatus For the Treatment of Feminine Pelvic Organ Prolapse |
US9060838B2 (en) | 2004-05-21 | 2015-06-23 | Coloplast A/S | Tissue supported implantable device |
WO2005112842A1 (en) * | 2004-05-21 | 2005-12-01 | Mpathy Medical Devices Limited | Implant for treatment of vaginal and/or uterine prolapse |
US8215310B2 (en) | 2004-05-21 | 2012-07-10 | Coloplast A/S | Implant for treatment of vaginal and/or uterine prolapse |
US7975698B2 (en) | 2004-05-21 | 2011-07-12 | Coloplast A/S | Implant for treatment of vaginal and/or uterine prolapse |
US10064714B2 (en) | 2004-05-21 | 2018-09-04 | Coloplast A/S | Implantable device configured to treat pelvic organ prolapse |
US20050288692A1 (en) * | 2004-06-15 | 2005-12-29 | Jean-Marc Beraud | Parietal hook |
US7758615B2 (en) | 2004-06-15 | 2010-07-20 | Colopast A/S | Parietal hook |
US20060173468A1 (en) * | 2005-01-28 | 2006-08-03 | Marc Simmon | Obturator introducer with snare |
US8617047B2 (en) | 2005-03-17 | 2013-12-31 | Contipi Ltd. | Apparatuses for the amelioration of urinary incontinence in females |
US9549798B2 (en) | 2005-03-17 | 2017-01-24 | Kimberly-Clark Worldwide, Inc. | Apparatuses for the amelioration of urinary incontinence in females |
US20080281149A1 (en) * | 2005-03-17 | 2008-11-13 | Contipi Ltd | Apparatuses for the Amelioration of Urinary Incontinence in Females |
WO2007031645A2 (en) * | 2005-09-14 | 2007-03-22 | B. Braun Medical Sas | Device and method for preventing female stress incontinence |
US20080228027A1 (en) * | 2005-09-14 | 2008-09-18 | Bernard Guerquin | Device and Process for Preventing Female Stress Urinary Incontinence |
US7736298B2 (en) | 2005-09-14 | 2010-06-15 | B. Braun Medical Sas | Device and process for preventing female stress urinary incontinence |
WO2007031645A3 (en) * | 2005-09-14 | 2008-06-12 | Braun Medical Sas | Device and method for preventing female stress incontinence |
FR2890554A1 (en) * | 2005-09-14 | 2007-03-16 | Braun Medical Sas Soc Par Acti | DEVICE AND METHOD FOR PREVENTING FEMALE URINARY INCONTINENCE IN THE EFFORT |
US10004584B2 (en) | 2006-07-10 | 2018-06-26 | First Quality Hygienic, Inc. | Resilient intravaginal device |
US8613698B2 (en) | 2006-07-10 | 2013-12-24 | Mcneil-Ppc, Inc. | Resilient device |
US8608639B2 (en) | 2006-07-10 | 2013-12-17 | Mcneil-Ppc, Inc. | Resilient device |
US8753258B2 (en) | 2006-07-10 | 2014-06-17 | Mcneil-Ppc, Inc. | Resilient device |
US7892163B2 (en) | 2006-07-10 | 2011-02-22 | Mcneil-Ppc, Inc. | Method of treating urinary incontinence |
US9050183B2 (en) | 2006-07-10 | 2015-06-09 | First Quality Hygienic, Inc. | Resilient device |
JP2009543606A (en) * | 2006-07-10 | 2009-12-10 | マクニール−ピーピーシー・インコーポレイテッド | Elastic device |
US8177706B2 (en) | 2006-07-10 | 2012-05-15 | Mcneil-Ppc, Inc. | Method of treating urinary incontinence |
US10219884B2 (en) | 2006-07-10 | 2019-03-05 | First Quality Hygienic, Inc. | Resilient device |
US7717892B2 (en) | 2006-07-10 | 2010-05-18 | Mcneil-Ppc, Inc. | Method of treating urinary incontinence |
US9173768B2 (en) | 2006-07-10 | 2015-11-03 | First Quality Hygienic, Inc. | Resilient device |
US8047980B2 (en) | 2006-07-10 | 2011-11-01 | Mcneil-Ppc, Inc. | Method of treating urinary incontinence |
US8911345B2 (en) | 2006-07-16 | 2014-12-16 | Kimberly-Clark Worldwide, Inc. | Apparatuses for the amelioration of urinary incontinence in females |
US9339361B2 (en) | 2006-07-16 | 2016-05-17 | Kimberly-Clark Worldwide, Inc. | Apparatuses for the amelioration of urinary incontinence in females |
US8435168B2 (en) | 2006-07-16 | 2013-05-07 | Contipi Ltd. | Apparatuses for the amelioration of urinary incontinence in females |
US20090318750A1 (en) * | 2006-07-16 | 2009-12-24 | Contipi Ltd | Apparatuses for the amelioration of urinary incontinence in females |
AU2013211480B2 (en) * | 2006-07-16 | 2015-06-04 | Kimberly-Clark Worldwide, Inc. | Apparatuses For The Amelioration Of Urinary Incontinence In Females |
US8302608B2 (en) | 2006-12-21 | 2012-11-06 | Oz Harmanli | Vaginal pessary |
US10507094B2 (en) | 2006-12-21 | 2019-12-17 | Oz Harmanli | Vaginal pessary |
US20090283099A1 (en) * | 2006-12-21 | 2009-11-19 | Oz Harmanli | Vaginal pessary |
US7645227B2 (en) | 2007-05-14 | 2010-01-12 | Ethicon, Inc. | Implants and methods for pelvic floor repair |
US8758359B2 (en) | 2007-05-14 | 2014-06-24 | Ethicon, Inc. | Instruments for implanting implantable prostheses |
US20080287968A1 (en) * | 2007-05-14 | 2008-11-20 | Smith Daniel J | Implants and methods for pelvic floor repair |
US20080287956A1 (en) * | 2007-05-14 | 2008-11-20 | Smith Daniel J | Instruments for implanting implantable prostheses |
US20110065980A1 (en) * | 2007-06-11 | 2011-03-17 | Contipi Ltd. | Adjustable tension ring for amelioration of urinary incontinence in females |
US9198748B2 (en) | 2007-06-11 | 2015-12-01 | Contipi Medical Ltd. | Adjustable tension ring for amelioration of urinary incontinence in females |
US9339363B2 (en) | 2007-10-01 | 2016-05-17 | Kimberly Clark Worldwide, Inc. | Management of urinary incontinence in females |
US20100217068A1 (en) * | 2007-10-01 | 2010-08-26 | Elan Ziv | Management of urinary incontinence in females |
US9675437B2 (en) | 2007-10-01 | 2017-06-13 | Kimberly-Clark Worldwide, Inc. | Management of urinary incontinence in females |
US10639138B2 (en) | 2008-02-28 | 2020-05-05 | Coloplast A/S | Method for providing support to a urethra in treating urinary incontinence |
US20090266367A1 (en) * | 2008-04-23 | 2009-10-29 | Contipi Ltd. | Pessaries for prolapse alleviation |
US9655769B2 (en) | 2008-04-23 | 2017-05-23 | Contipi Medical Ltd. | Pessaries for prolapse alleviation |
US8651109B2 (en) | 2008-04-23 | 2014-02-18 | Contipi Ltd. | Pessaries for prolapse alleviation |
WO2010138892A2 (en) | 2009-05-28 | 2010-12-02 | Contine Corporation | Correction of stress urinary incontinence |
EP2434983A4 (en) * | 2009-05-28 | 2014-07-16 | Contine Corp | Correction of stress urinary incontinence |
EP2434983A2 (en) * | 2009-05-28 | 2012-04-04 | Contine Corporation | Correction of stress urinary incontinence |
US20180132991A1 (en) * | 2010-04-02 | 2018-05-17 | Gynamics Women's Health Ltd. | Medical device for treatment of urinary incontinence in females |
US10709536B2 (en) * | 2010-04-02 | 2020-07-14 | Gynamics Women's Health Ltd. | Medical device for treatment of urinary incontinence in females |
KR101536089B1 (en) * | 2011-12-20 | 2015-07-10 | 킴벌리-클라크 월드와이드, 인크. | Vaginal insert device having perpendicular segments |
EP2793779A4 (en) * | 2011-12-20 | 2015-09-16 | Kimberly Clark Co | Vaginal insert device having perpendicular segments |
US20130158340A1 (en) * | 2011-12-20 | 2013-06-20 | Amanda Rae Altan | Vaginal Insert Device Having Perpendicular Segments |
US8911344B2 (en) * | 2011-12-20 | 2014-12-16 | Kimberly-Clark Worldwide, Inc. | Vaginal insert device having perpendicular segments |
US20160016040A1 (en) * | 2012-06-04 | 2016-01-21 | Caryn M. Horsley | Medical Exercise Device |
US20150351886A1 (en) * | 2013-01-17 | 2015-12-10 | Carey Tasca Pty Ltd | Surgical vaginal support device for surgical treatment of pelvic organ prolapse |
ES2577537A1 (en) * | 2016-03-22 | 2016-07-15 | Carmen Rocio SIERRA LABARTA | Collector and urine separator for women (Machine-translation by Google Translate, not legally binding) |
US10441402B2 (en) | 2016-07-25 | 2019-10-15 | Rinovum Subsidiary 2, LLC | Incontinence device |
WO2018022487A1 (en) * | 2016-07-25 | 2018-02-01 | Rinovum Subsidiary 2, LLC | Incontinence device |
US10441401B2 (en) | 2016-07-25 | 2019-10-15 | Rinovum Subsidiary 2, LLC | Incontinence device |
WO2018022492A1 (en) * | 2016-07-25 | 2018-02-01 | Rinovum Subsidiary 2, LLC | Incontinence device |
US11135047B2 (en) | 2016-07-25 | 2021-10-05 | Ovala, Inc. | Incontinence device |
AU2017302514B2 (en) * | 2016-07-25 | 2022-05-19 | Ovala, Inc. | Incontinence device |
US11141255B2 (en) | 2017-04-26 | 2021-10-12 | Ovala, Inc. | Introducer for urinary incontinence |
USD833009S1 (en) | 2017-07-24 | 2018-11-06 | Rinovum Subsidiary 2, LLC | Incontinence device |
USD832437S1 (en) | 2017-07-24 | 2018-10-30 | Rinovum Subsidiary 2, LLC | Incontinence device |
Also Published As
Publication number | Publication date |
---|---|
US6460542B1 (en) | 2002-10-08 |
WO2002053071A8 (en) | 2002-08-08 |
GB0216120D0 (en) | 2002-08-21 |
WO2002053071A1 (en) | 2002-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6460542B1 (en) | Female incontinence control device | |
AU2003233612B2 (en) | C-shaped vaginal incontinence insert | |
AU2003230382B2 (en) | Molar shaped vaginal incontinence insert | |
US5386836A (en) | Urinary incontinence device | |
US6808485B2 (en) | Compressible resilient incontinence insert | |
JP2581932B2 (en) | Intravaginal device | |
EP0498912B1 (en) | A device for controlling female incontinence | |
US20170086956A1 (en) | Foldable Pessary for Treatment of Stress Urinary Incontinence | |
EP0460807A2 (en) | Urinary incontinence device | |
AU614940B2 (en) | Urinary incontinence device | |
AU606408B2 (en) | Female incontinence device | |
NZ222169A (en) | Intra-vaginal, urinary incontinence control device | |
CA2035913A1 (en) | Device for controlling female incontinence |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: JAMES, LARRY W., MISSOURI Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MEDICAL TECHNOLOGY & INNOVATIONS, INC.;REEL/FRAME:012960/0762 Effective date: 20020729 Owner name: MEDICAL TECHNOLOGY & INNOVATIONS, INC., FLORIDA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:JAMES, LARRY W.;REEL/FRAME:012960/0559 Effective date: 20001227 |
|
FEPP | Fee payment procedure |
Free format text: PETITION RELATED TO MAINTENANCE FEES FILED (ORIGINAL EVENT CODE: PMFP); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
REMI | Maintenance fee reminder mailed | ||
REIN | Reinstatement after maintenance fee payment confirmed | ||
FEPP | Fee payment procedure |
Free format text: PETITION RELATED TO MAINTENANCE FEES GRANTED (ORIGINAL EVENT CODE: PMFG); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20061008 |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
SULP | Surcharge for late payment | ||
PRDP | Patent reinstated due to the acceptance of a late maintenance fee |
Effective date: 20070110 |
|
REMI | Maintenance fee reminder mailed | ||
FPAY | Fee payment |
Year of fee payment: 8 |
|
SULP | Surcharge for late payment |
Year of fee payment: 7 |
|
REMI | Maintenance fee reminder mailed | ||
LAPS | Lapse for failure to pay maintenance fees | ||
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20141008 |